Related Experiment Video
Updated: Sep 18, 2025
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
363
Qatar's Progress in Curbing Diabetes: A Comprehensive and Proactive Approach
Mohamed Hamad J T Al-Thani1, Sameh El-Saharty2, Zeina Jamal1
1Department of Non-Communicable Diseases Prevention Programs, Ministry of Public Health, Doha, Qatar.
Health Systems and Reform
|June 23, 2025
Summary
Qatar is tackling Type 2 diabetes and non-communicable diseases with a national strategy. Recent data shows stabilized rates, highlighting the need for continued public health efforts and innovative digital health solutions.
Area of Science:
- Public Health
- Endocrinology
- Health Policy
Background:
- The Gulf Cooperation Council region faces a high prevalence of Type 2 diabetes mellitus (T2DM) and non-communicable diseases.
- Qatar's 2012 STEPwise survey identified a T2DM prevalence of 16.7%, prompting national action.
Purpose of the Study:
- To examine Qatar's comprehensive strategy in managing T2DM and related non-communicable diseases.
- To evaluate the impact of national initiatives on disease prevalence and public health outcomes.
Main Methods:
- Analysis of data from the 2012 and 2023 STEPwise surveys.
- Review of Qatar's National Diabetes Strategy (2016-2022) and upcoming National Health Strategy (NHS-3).
- Examination of technological and digital health interventions in diabetes care and surveillance.
Main Results:
- Diabetes prevalence stabilized at 18.1% and obesity at 33.4% in 2023, indicating a plateau in rates.
- Qatar has implemented a multi-pillar national strategy, including taskforces for obesity and childhood diabetes.
- Innovative technologies and digital health are being utilized to improve diabetes management and surveillance.
Conclusions:
- Qatar's proactive, multi-faceted approach demonstrates a commitment to controlling diabetes and non-communicable diseases.
- Ongoing public health interventions and strategic planning are crucial for sustained progress.
- Qatar aims to serve as a model for other nations addressing similar health challenges through partnerships and research.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
410
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
410
01:22Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
01:15Diabetes: Symptoms, Diagnosis, and Complications
709
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
709
01:22Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
01:20Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
01:30Preventive Healthcare Services
1.1K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.1K